With 63595.0 shares changed hands, the volume of the stock remained lighter than its average volume of 2.3 million shares. During the session, the Medical Devices company that operates in wider Healthcare sector, reached to the highest price of $4.0999 whereas the lowest price it dropped to was $3.785. The 52-week range on AIMD shows that it touched its highest point at $5.00 and its lowest point at $2.00 during that stretch. Beta for the stock currently stands at 2.29.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of AIMD was up-trending over the past week, with a rise of 7.30%, but this was up by 46.92% over a month. Three-month performance surged to 13.19% while six-month performance rose 43.21%. The stock gained 67.54% in the past year, while it has gained 16.82% so far this year.
Float and Shares Shorts:
At present, 4.27 million AIMD shares are outstanding with a float of 1.67 million shares on hand for trading. On 2025-08-15, short shares totaled 0.15 million, which was 313.00000000000006 higher than short shares on 1752537600. In addition to Mr. Chun-Hsien Tsai as the firm’s CEO, President & Chairman of the Board, Mr. Hsin-Liang Lee serves as its Chief Financial Officer.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2025-06-30, AIMD reported revenue of $4663.0 and operating income of -$3745687.0. The EBITDA in the recently reported quarter was -$2712861.0 and diluted EPS was -$0.99.
